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Abstract: Polysaccharide-based aerogels in the form of microspheres were investigated as carriers of 
poorly water soluble drugs for oral administration. These bio-based carriers may combine the 
biocompatibility of polysaccharides and the enhanced drug loading capacity of dry aerogels. Aerogel 
microspheres from starch, pectin and alginate were loaded with ketoprofen (anti-inflammatory drug) 
and benzoic acid (used in the management of urea cycle disorders) via supercritical CO2-assisted 
adsorption. Amount of drug loaded depended on the aerogel matrix structure and composition and 
reached values up to 1.0×10-3 and 1.7×10-3 g/m2 for ketoprofen and benzoic acid in starch 
microspheres. After impregnation, drugs were in the amorphous state in the aerogel microspheres. 
Release behavior was evaluated in different pH media (pH 1.2 and 6.8). Controlled drug release from 
pectin and alginate aerogel microspheres fitted Gallagher-Corrigan release model (R2>0.99 in both 
cases), with different relative contribution of erosion and diffusion mechanisms depending on the 
matrix composition. Release from starch aerogel microspheres was driven by dissolution, fitting the 
first-order kinetics due to the rigid starch aerogel structure, and showed different release rate constant 
(k1) depending on the drug (0.075 and 0.160 min-1 for ketoprofen and benzoic acid, respectively). 
Overall, the results point out the possibilities of tuning drug loading and release by carefully choosing 
the polysaccharide used to prepare the aerogels. 
 
 
 
 
HIGHLIGHTS 
- Polysaccharide aerogel microspheres are investigated as carriers of drugs for oral administration 
- Aerogels were loaded with ketoprofen and benzoic acid, poorly water soluble model drugs 
- Starch, with the lowest specific surface area, was more prone to adsorb drug molecules 
- Release of ketoprofen from alginate and pectin aerogel particles was sensitive to pH of the medium 
- Results point out the possibilities of polysaccharide aerogels of tuning drug loading and release 
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Abstract 18 
Polysaccharide-based aerogels in the form of microspheres were investigated as carriers of poorly 19 
water soluble drugs for oral administration. These bio-based carriers may combine the 20 
biocompatibility of polysaccharides and the enhanced drug loading capacity of dry aerogels. Aerogel 21 
microspheres from starch, pectin and alginate were loaded with ketoprofen (anti-inflammatory drug) 22 
and benzoic acid (used in the management of urea cycle disorders) via supercritical CO2-assisted 23 
adsorption. Amount of drug loaded depended on the aerogel matrix structure and composition and 24 
reached values up to 1.0×10
-3
 and 1.7×10
-3
 g/m
2
 for ketoprofen and benzoic acid in starch 25 
microspheres. After impregnation, drugs were in the amorphous state in the aerogel microspheres. 26 
Release behavior was evaluated in different pH media (pH 1.2 and 6.8). Controlled drug release from 27 
pectin and alginate aerogel microspheres fitted Gallagher-Corrigan release model (R
2
>0.99 in both 28 
cases), with different relative contribution of erosion and diffusion mechanisms depending on the 29 
matrix composition. Release from starch aerogel microspheres was driven by dissolution, fitting the 30 
first-order kinetics due to the rigid starch aerogel structure, and showed different release rate constant 31 
(k1) depending on the drug (0.075 and 0.160 min
-1
 for ketoprofen and benzoic acid, respectively). 32 
Overall, the results point out the possibilities of tuning drug loading and release by carefully choosing 33 
the polysaccharide used to prepare the aerogels. 34 
Keywords: polysaccharide-based aerogel; ketoprofen; benzoic acid; supercritical impregnation; drug 35 
release kinetics 36 
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1 Introduction 38 
Bio-based materials may become key formulation ingredients for the engineering of delivery systems 39 
able to overcome the biopharmaceutical and stability limitations shown by a number of well-40 
established drugs and new chemical entities (García-González, Alnaief & Smirnova, 2011; García-41 
González, Argemí, Sousa, Duarte, Saurina & Domingo, 2010; Pose-Vilarnovo et al., 2004). Natural 42 
polysaccharides and/or their derivatives are especially attractive because of their availability, 43 
renewability, low toxicity, stability upon storage, good biological performance, and enzyme-controlled 44 
biodegradability (Baldwin & Kiick, 2010; Dumitriu, 2012; García-González, Alnaief & Smirnova, 45 
2011; Veronovski, Knez & Novak, 2013). Technological advances in extraction and purification 46 
processes enable the cost-effective obtaining of natural polysaccharides in large-scale, rendering them 47 
interesting for life science applications, e.g., pharmacy, tissue engineering and environmental 48 
remediation (Alvarez-Lorenzo, Blanco-Fernandez, Puga & Concheiro, 2013; Baldwin & Kiick, 2010; 49 
Kayser, Müller, García-González, Smirnova, Leitner & Domínguez de María, 2012). Several 50 
polysaccharide-based drug delivery systems (e.g., Lupron Depot
® 
and Nutropin Depot
®
) can already 51 
be found in the market (Kim & Pack, 2006). 52 
Polysaccharide-based aerogels for drug delivery and biomedical systems were firstly proposed by 53 
Berg et al. (Berg, Droege, Fellmann, Klaveness & Rongved, 1995) and since then there has been an 54 
increasing interest on the research of these materials for pharmaceutical technology purposes (García-55 
González, Alnaief & Smirnova, 2011; Ulker & Erkey, 2014). Aerogel technology provides high 56 
added-value lightweight materials with outstanding surface area and open porosity, suitable to be 57 
loaded with active substances. Organic aerogels prepared with US Food and Drug Administration 58 
(FDA)- and European Medicines Agency (EMA)-approved bio-based polysaccharides offer unique 59 
features as drug carriers by combining the intrinsic properties of the aerogel structure and those of the 60 
polysaccharides. Moreover, aerogel carriers may load high amounts of drugs, improve their stability, 61 
and control the crystalline form of the drug (García-González & Smirnova, 2013; Smirnova, 62 
Suttiruengwong & Arlt, 2004). Drug loading within starch aerogels has been reported to be in the 63 
range 1–4 × 10−3 g/m2 for ibuprofen in starch aerogel monoliths (Mehling, Smirnova, Guenther & 64 
Neubert, 2009) or ketoprofen in starch aerogel particles (García-González & Smirnova, 2013), which 65 
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is larger than the values obtained for silica aerogels (3.8×10
-4
 g/m
2
), an aerogel reference material. 66 
Using the supercritical ﬂuid-assisted drug impregnation, drugs are loaded in a non-crystalline form 67 
(Mehling, Smirnova, Guenther & Neubert, 2009). Accordingly, ibuprofen and ketoprofen-loaded 68 
organic aerogel monoliths and beads (corn starch and alginate) showed faster drug dissolution rate 69 
than the crystalline drug (Del Gaudio, Auriemma, Mencherini, Porta, Reverchon & Aquino, 2013; 70 
Mehling, Smirnova, Guenther & Neubert, 2009). 71 
Aerogels produced in the form of microspheres (Valentin, Molvinger, Quignard & Di Renzo, 2005) 72 
are preferred as drug carriers to other aerogel formats, such as monoliths (García-González, Camino-73 
Rey, Alnaief, Zetzl & Smirnova, 2012), granules (Hong, Yoon & Hwang, 2011), powders (Bhagat, 74 
Park, Kim, Kim & Han, 2008) or beads (Sarawade, Kim, Hilonga, Quang, Jeon & Kim, 2011). This 75 
preference for the microspherical form arises from its high flowability, ease of handling, and improved 76 
processing reproducibility coupled to reduced triggering of inflammatory response due to the inherent 77 
absence of sharp edges (Hong, Yoon & Hwang, 2011; Radin, Chen & Ducheyne, 2009). Release of 78 
active pharmaceutical ingredients (API) from microspheres is a complex process being influenced by 79 
various factors that could lead to totally different release profiles. Porous network collapse of aerogel 80 
carriers once in contact with aqueous medium notably influences API release. Erosion (by dissolution 81 
or hydrolysis) rate depends on the structure and the molecular weight of the polymer, the morphology 82 
and size of the carrier, as well as the medium conditions (pH, temperature, enzymes). Polymeric 83 
microspheres may erode from the bulk (homogeneous) or from carrier surface (heterogeneous) 84 
depending on the relative ratio of water penetration rate to polymer network hydrolysis rate being high 85 
or low, respectively, (Rothstein, Federspiel & Little, 2009; von Burkersroda, Schedl & Göpferich, 86 
2002) thus influencing the API release into the environment (Kim & Pack, 2006; O'Donnell & 87 
McGinity, 1997). Finally, chemical interactions between the drug and the carrier may also influence 88 
the release rate. 89 
There is still a paucity of information about the effect of the polysaccharide source used to prepare 90 
microspherical aerogels on their ability to load and to control the release of active substances. 91 
Polysaccharide nature may likely influence the aerogel collapse and, subsequently, the mass transport 92 
and release proﬁle of the drug contained in the aerogel as well. The aim of this work was to evaluate 93 
5 
the drug loading and release behavior of aerogel microspheres prepared from three polysaccharides 94 
(starch, alginate, and pectin) according to an emulsion-gelation method followed by supercritical 95 
drying, in order to elucidate their potential as carriers of poorly water soluble drugs for oral 96 
administration. Ketoprofen and benzoic acid were loaded into the aerogels by supercritical (sc)CO2 97 
fluid-assisted impregnation. Silica aerogel microspheres were used as aerogel reference regarding drug 98 
loading capacity and release for the sake of comparison. Drug release kinetics from polysaccharide 99 
aerogel microspheres were evaluated at gastric and intestinal pH conditions. To the best of our 100 
knowledge, this work represents the first systematic study in the fast developing field of the 101 
microformulation of supports for drug release using aerogels in the form of microspheres as drug 102 
carrier. 103 
2 Materials and methods 104 
2.1 Reagents 105 
Native corn starch (Starch amylo N-460; 52.6% amylose content) was from Roquette (France); alginic 106 
acid sodium salt (brown algae origin, G/M ratio of 70/30, MW 403,000 g·mol
-1
) from Sigma Aldrich 107 
(Germany); citrus high methoxyl pectin (63-66% degree of esterification, MW 30,000-100,000 g·mol
-1
) 108 
and tetramethoxysilane (TMOS, purity of 98%) from Fluka (Germany). Methanol (95%), hydrochloric 109 
acid (30%), ammonium hydroxide (25%) and benzoic acid (98%) were from Merck (Germany). 110 
Ketoprofen (racemic mixture) was from Chemische Fabrik Kreussler & Co. GmbH (Germany). 111 
Ethanol (99.8%) was from Omnilab (Germany) and domestic grade rapeseed oil was purchased from 112 
Brökelmann Co. (Germany). Carbon dioxide was supplied by AGA Gas GmbH (Germany).  113 
2.2 Preparation of spherical aerogel microspheres 114 
Aerogel microspheres were obtained applying an emulsion-gelation method followed by supercritical 115 
drying. In brief, this method consisted on the preparation of a water-in-oil emulsion (or ethanol-in-oil 116 
for silica gel microspheres) followed by the gelation of the dispersed phase (thermal gelation for starch 117 
and chemical gelation for alginate, pectin and silica) as previously reported (Alnaief, Alzaitoun, 118 
García-González & Smirnova, 2011; Alnaief & Smirnova, 2011; García-González, Uy, Alnaief & 119 
Smirnova, 2012). Gel microspheres were isolated through centrifugation and exposed to ethanol for 120 
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solvent exchange. Finally, aerogel microspheres were obtained by scCO2-assisted drying. The 121 
operating conditions used in this work for the preparation of aerogel microspheres correspond to the 122 
ones reported in the literature leading to the highest (or close to the highest) specific surface area 123 
values so far for each aerogel case using processing approaches compatible with the intended 124 
application (i.e., oral drug delivery). Operating conditions for the processing of the aerogel 125 
microspheres were chosen so that mean pore diameters in the range 14-18 nm were obtained in all 126 
cases to neglect the effect of this variable in the study. For more detailed instructions on the 127 
preparation of the aerogels, please refer to the Appendix A in Supplementary Data section. 128 
2.3 Ketoprofen and benzoic acid supercritical impregnation 129 
Alginate, starch, silica or pectin aerogel microspheres (0.12 g) and active compounds (0.12 g of 130 
ketoprofen or benzoic acid) were wrapped separately in filter paper cartridges. Then, a set of two 131 
cartridges (one containing microspheres and the other with the drug) were placed in one of the reactors 132 
of the apparatus sketched in Figure 1. Control trials (one reactor containing a drug cartridge alone and 133 
other containing one cartridge for each aerogel type) were carried out in the two remaining reactors. 134 
Experiments were carried out in duplicate. The supercritical impregnation setup used for these 135 
experiments not only provides a high-throughput trial program by means of its six reactors arranged in 136 
parallel (namely, six experiments can be carried out at the same time), but also improves the 137 
reproducibility of the experiments since all trials from the same batch series share the same CO2 138 
pressurization/depressurization cycle and heat transfer histories. scCO2–assisted impregnation 139 
conditions were optimized for ketoprofen (40 ºC, 18.0 MPa) and benzoic acid (55 ºC, 18.0 MPa) 140 
following guidelines of solubility of active compounds in scCO2 (Jin, Zhong, Zhang & Li, 2004; Stassi, 141 
Bettini, Gazzaniga, Giordano & Schiraldi, 2000). Impregnation times were chosen long enough (24h) 142 
to neglect the effect of aerogel microparticle size in the drug loading achieved. Impregnation 143 
conditions were kept constant under agitation at 500 rpm. 144 
2.4 Aerogel microsphere characterization 145 
Specific surface area of the bare aerogel microspheres was quantified from low-temperature N2 146 
adsorption-desorption data (Nova 3000e, Quantachrome, USA). Prior to measurements, samples were 147 
7 
dried for 20 h under vacuum (<1 mPa) at 60ºC for alginate and pectin, 80ºC for starch and 200ºC for 148 
silica aerogels. Mean particle size of wet gel microspheres dispersed in ethanol was estimated by 149 
means of laser diffraction spectrometry (Beckman Coulter LS1332) and using similar obscuration 150 
values (9-11%) for all samples. Morphology of the polysaccharide aerogel microspheres as well as 151 
silica microspheres was evaluated using scanning electron microscopy (SEM, Leo Zeiss 1530, 152 
Germany). Morphology and physical integrity of aerogels in contact with water were monitored with 153 
aid of high-speed camera by depositing 100 picoliter-water droplets on microsphere surfaces (DSA 154 
100M provided by Krüss GmbH, Germany). X-ray diffraction analysis (XRD, Siemens D500 155 
diffractometer equipped with a diffracted beam monochromator, Germany) of the drug-loaded and 156 
unloaded microspheres as well as aerogel-plus-drug physical mixtures was carried out using a 157 
position-sensitive detector and CuKα radiation within the range of 2° to 40° 2θ and a step size of 0.05º. 158 
For determination of drug entrapment efficiency, drug-loaded microspheres (10-50 mg) were 159 
dispersed in a known volume of ethanol (sink conditions) and sonicated for 30 min, which was 160 
enough for complete drug release. Afterwards the solution was filtered through a 0.22 µm membrane 161 
filter (Millipore syringe filter, PTFE, EW-29950-42, Cole-Parmer, USA) and the absorbance at 255 162 
nm (ketoprofen) or 227 nm (benzoic acid) measured (Evolution 300 UV spectrophotometer, Thermo 163 
Scientific, USA).  164 
2.5 In vitro drug release  165 
Dissolution test was conducted according to the Ph. Eur. guidelines in 0.1 M phosphate buffer saline 166 
(PBS, simulated intestinal fluid, pH 6.8) or in 0.1 N HCl (simulated gastric fluid, pH 1.2) solutions 167 
using a paddle apparatus (Sotax At7, Allschwil, Switzerland) with a constant agitation speed of 100 168 
rpm at 37 °C. Drug-loaded aerogel microspheres (20-50 mg) were immersed in jars containing 900 mL 169 
buffer medium (sink conditions). Samples (2 mL) were withdrawn at determined time intervals and 170 
filtered through a 0.22 µm membrane filter. Each drug release test lasted for 24 h and was run in 171 
duplicate. Drug concentration was determined by means of UV spectrophotometry, as described in 172 
section 2.4. 173 
174 
8 
3 Results and discussion 175 
3.1 Characterization of the drug-loaded aerogel microspheres 176 
Aerogel microspheres were obtained by means of an emulsion-gelation method coupled to 177 
supercritical drying, in the form of a powder constituted by non-agglomerated particles of mean 178 
particle size in the range of 100 to 550 µm (Table 1) depending on the nature of the precursor. 179 
Alginate and silica aerogel microspheres showed the lowest mean particle diameters. Particle sizes of 180 
aerogel microspheres are mainly influenced by the gelation process and chemical composition (i.e. 181 
gelation mechanism, cross-linker, viscosity of the emulsion, emulsifier used or stirring rate among 182 
others) (García-González, Alnaief & Smirnova, 2011; García-González, Uy, Alnaief & Smirnova, 183 
2012). Resulting aerogels showed low density (ρ<0.25 g/cm3), high porosity (ε>85%) and high 184 
specific surfaces area (>100 m
2
/g, Table 1). Specific surface areas of pectin and alginate aerogels were 185 
much higher than those of starch aerogels, but still significantly lower than that of silica aerogel. The 186 
values for the specific surface area depend on the three-dimensional structure of the gel, which is 187 
mainly governed by the degree of crosslinking of the gel (García-González, Alnaief & Smirnova, 188 
2011). For starch aerogels, higher specific surface area is accordingly obtained by using a high 189 
amylose content starch source that provides a less-ordered amorphous network structure, a gelation 190 
temperature high enough to promote full disruption of the original starch granules and a low 191 
retrogradation temperature favoring crystal nucleation rather than crystal growth (García-González & 192 
Smirnova, 2013; Mehling, Smirnova, Guenther & Neubert, 2009). For Ca-alginate aerogels, an 193 
increase in the calcium cross-linker salt concentration and in the alginate concentration leads to an 194 
increased degree of cross-linking (egg-box model) and a subsequent increase in the specific surface 195 
area obtained (Alnaief, Alzaitoun, García-González & Smirnova, 2011). For pectin aerogels, the 196 
choice of the pectin source (with different degrees of esterification) and the gelation mechanism 197 
(acidic, thermal or ionic gelation mechanism) largely influences the physical stability and specific 198 
surface area of the aerogel (García-González, Carenza, Zeng, Smirnova & Roig, 2012; White, Budarin 199 
& Clark, 2010). 200 
SEM images of aerogel microspheres before and after impregnation with ketoprofen and benzoic acid 201 
(Fig. 2) revealed no significant morphological changes in the matrix due to drug impregnation via 202 
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scCO2 technology. High magnifications (Fig. 2,right) evidenced that drug loading did not affect the 203 
nanoporous structure of matrices and no sharp edges typical for drug crystals were observed in any of 204 
the ketoprofen or benzoic acid-loaded microspheres. 205 
Production of the aerogel microspheres through emulsion-gelation did not influence the crystallinity of 206 
the polysaccharide matrix, as confirmed by XRD analysis (Fig. 3). Moreover, the absence of the 207 
characteristic peaks of ketoprofen (6.4, 18.2 and 23.2º 2) and benzoic acid (8.2° 2) in the respective 208 
drug-loaded aerogel microspheres confirmed the absence of drug crystals in the aerogels. Conversely, 209 
peaks corresponding to benzoic acid and ketoprofen crystals were observed for the physical mixtures 210 
of each drug with ground powders of starch microspheres (Figs. 3d and 3g) prepared at similar mass 211 
ratio as in the drug-impregnated aerogels; thus it was discarded that the XRD sensitivity was not high 212 
enough to detect the presence of drug crystals in the drug-loaded aerogels. Moreover, control trials 213 
with the drugs processed at the same supercritical operating conditions used for drug impregnation in 214 
aerogels show neither change in the XRD-pattern with respect to the raw drug nor the appearance of 215 
any polymorph of the drug. Amorphisation of the drug loaded in the aerogel matrices should be linked 216 
to the impregnation process itself. 217 
Contact angle measurement test by applying a water droplet to the aerogel microsphere surfaces was 218 
used to determine their hydrophilicity/hydrophobicity as well as to get an indication of the aerogel 219 
structure integrity behavior and morphology in presence of water. Due to the porous structure of 220 
aerogel microspheres, water droplet was absorbed into the network and disappeared in few 221 
milliseconds (Fig. 4). Afterwards, polymer erosion occurred for aerogels and the structure collapsed at 222 
different velocities and intensities depending on the type of polymeric material. Starch microspheres 223 
showed more resistance against hydration, whereas silica and pectin microspheres were prone to a 224 
rapid collapse of the porous network once in contact to water. Any conclusion can be poorly derived 225 
for alginate microspheres based on the sensitivity of the measurement method due to the small 226 
diameter of the aerogel, although a sudden material collapse seems to appear just after water 227 
deposition (Fig. 4-bottom center). The observed pore collapse is a physical degradation taking place 228 
due to mechanical stresses: upon contact with an aqueous medium and due to the liquid/air interfacial 229 
surface tension, the open nanoporous structure of hydrophilic aerogels allows the penetration of water 230 
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therein resulting in large capillary forces taking place and inducing compression stresses enough to 231 
collapse the aerogel network (Hüsing & Schubert, 1998). In general, a more rapid matrix collapse may 232 
accelerate drug release (Kim & Pack, 2006; Mathiowitz et al., 1997; Shen, Kipper, Dziadul, Lim & 233 
Narasimhan, 2002; Spenlehauer, Vert, Benoit & Boddaert, 1989). Even though erosion is not the only 234 
factor influencing the drug release process, this experiment may shed light on detection of erosion 235 
during the drug dissolution process and to what extent it may play a role in releasing drug molecules 236 
into the medium. 237 
3.2 Drug entrapment efficiency 238 
Ketoprofen and benzoic acid were loaded into the aerogels by supercritical impregnation. The 239 
preference for supercritical impregnation of aerogels rather than other drug loading techniques (e.g., 240 
before gelation or during solvent exchange) stems from the poor solubility in water and good 241 
solubility in scCO2 of these drugs, thus leading to higher drug loadings of the aerogels in the former 242 
case (García-González, Alnaief & Smirnova, 2011). As a rule-of-thumb, the highest drug loading 243 
capacities of aerogels are usually correlated with the largest specific surface area. Accordingly, silica 244 
aerogel microparticles had the highest drug loading for both ketoprofen and benzoic acid, among the 245 
four types of microspheres tested (Table 1). Nevertheless, drug loading of alginate, starch and pectin 246 
microparticles did not obey the same tendency and was also dependent on the drug to be loaded. 247 
Moreover, starch aerogel microspheres were more prone to adsorb drug molecules since they 248 
presented the highest specific loading capacity for ketoprofen among the aerogels tested. These 249 
findings suggest that, apart from specific surface area, other factors such as surface chemistry and 250 
API-aerogel carrier interaction may also influence the drug adsorption when using different sources of 251 
polymer matrices and thus determining the percentage of drug loading in the aerogel. Specific loading 252 
values for ketoprofen were lower than those expected for a monolayer coverage (1.7-2.1×10
-3
 g/m
2
) in 253 
all cases. Ketoprofen adsorption coverages in the aerogels below the monolayer coverage might be 254 
explained by surface hydroxyl group density in the aerogel and the competitive physisorption of CO2 255 
molecules during the supercritical fluid-assisted impregnation process (Gorle, Smirnova & Arlt, 2010; 256 
Tripp & Combes, 1998). Ketoprofen interacts with hydroxyl groups in the aerogel by hydrogen 257 
bonding through the carbonyl and carboxyl groups present in this drug molecule (Lozano & Martínez, 258 
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2006). The density of OH groups in starch aerogels is estimated to be 4–10 times higher than that of 259 
silica aerogels (García-González, Camino-Rey, Alnaief, Zetzl & Smirnova, 2012). Starch is also the 260 
only polysaccharide used in this study without acid groups in its molecular structure, thus avoiding the 261 
electrostatic repulsions of the drug molecules that may take place for the other polysaccharides. 262 
Stronger chemical interaction between the adsorbed drug molecules and the starch matrices might be 263 
thus behind the observed behavior of high ketoprofen specific loadings compared to the other aerogels. 264 
Moreover, starch (mainly amylose) can adopt helical structures with a hydrophobic cavity able to host 265 
drugs, such as benzoic acid (Uchino, Tozuka, Oguchi & Yamamoto, 2002) and recently reported for 266 
ketoprofen (Messner, Häusler & Loftsson, 2012), leading to the formation of inclusion complexes, 267 
which should contribute to greater drug uptakes. Namely, benzoic acid was reported to induce changes 268 
in the amylose helical structure to form inclusion complexes of amylose with the drug by using the 269 
sealed-heating process (Uchino, Tozuka, Oguchi & Yamamoto, 2002). This processing technique 270 
stems from the ability of evaporation of the drug at a given temperature to access the amylose helical 271 
structure and form the inclusion complex, observed through the appearance of XRD peaks at 6.8, 12.9, 272 
18.0º 2θ in the case of benzoic acid. Analogously, the supercritical impregnation process might be a 273 
low-temperature alternative to the sealed-heating process able to incorporate the benzoic acid in the 274 
helical amylose cavities due to the inherently low viscosity and high diffusivity of the supercritical 275 
solutions containing the drug. Evidences of inclusion formation by XRD in the benzoic acid-loaded 276 
starch aerogel cannot be confirmed in Fig 3e due to the low degree of crystallinity of the sample 277 
arising from its high amylose content and low hydration (Cheetham & Tao, 1998). Nevertheless, the 278 
presence of an incipient peak at 18.0º 2θ (as indicated by an asterisk in the figure), main diffraction 279 
peak of benzoic acid–71-helix structure amylose inclusion complex, seems to indicate the formation of 280 
an inclusion complex between benzoic acid and the starch (amylose) matrix. For the other aerogels 281 
loaded with benzoic acid, the specific loadings lies in the region of 2-4 × 10
-4
 g benzoic acid/m
2
 where 282 
the absence of drug crystals was previously reported (Gorle, Smirnova & Arlt, 2010). Overall, benzoic 283 
acid loading and drug entrapment efficiency values were much higher than ketoprofen loading ones 284 
regardless of the polymer matrix considered. This can be explained by the much lower molecular 285 
weight of benzoic acid (122.12 g/mol for benzoic acid and 254.28 g/mol for ketoprofen) as well as the 286 
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configuration of benzoic acid molecule (flat molecule: 0.50 nm×0.72 nm) compared to ketoprofen 287 
molecule (3D-molecule: 0.50 nm×1.22 nm×0.45nm). 288 
3.3 Release of ketoprofen and benzoic acid  289 
For drug delivery systems composed of biodegradable and water-soluble organic materials, three 290 
important factors –diffusion, dissolution and polymeric matrix erosion upon degradation – can be 291 
involved in the drug release process. In vitro cumulative release profiles of ketoprofen from different 292 
types of polysaccharide aerogel microspheres in pH 6.8 buffer solution are shown in Fig. 5. Similar 293 
patterns were observed in all cases, i.e. an initially fast dissolution rate during the first two hours was 294 
followed by a sustained release up to reaching a plateau. During these two hours, alginate and pectin 295 
microspheres released ca. 80% of the total ketoprofen impregnated, whereas starch microspheres 296 
released only 54.5%. The faster release rate of alginate and pectin microspheres in comparison to 297 
starch ones may stem from the matrix interaction with the aqueous medium and also from the weaker 298 
drug-matrix interactions. Pectin (Vaclavik & Christian, 2007) and alginate (Berger, Ludwig & Wielich, 299 
1953) are proved to be highly hydrophilic leading to rapid collapse of the aerogel porous network in 300 
aqueous medium; thus, amorphous drug molecules can be released to the buffer solution. Besides, the 301 
different drug release rate from alginate and pectin microspheres in comparison to that from starch 302 
microparticles may stem from the higher specific surface areas of the former ones (Table 1). The 303 
slightly incomplete release observed for pectin microspheres (82.02 % at 1440 min) compared to 304 
alginate ones, can be explained by the combination of lower specific surface area, larger particle size 305 
of pectin and drug-matrix chemical interactions. 306 
The release of ketoprofen contained in silica aerogel microspheres, a non-biodegradable polymeric 307 
matrix, showed a prompt drug release (60% in the first 60 min) followed by a slow release of 2% 308 
within the next 23 h (Fig. 5). The high specific surface area of silica aerogels facilitates the release of 309 
larger amounts of ketoprofen as a burst compared to the release of the drug from the polysaccharide 310 
aerogels. The non-degradability of silica under the release conditions coupled to the dramatic blockage 311 
of the drug in the inner core of the silica micropheres due to the porous network collapse observed for 312 
these aerogels once in contact with water may hinder the release by diffusion of the remaining 313 
ketoprofen to the surrounding medium. 314 
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Three mathematical models (Korsmeyer-Peppas model (Eq. (1)), first-order model (Eq. (2)) and 315 
Gallagher-Corrigan model (Eq(3))) emphasizing on different release phenomena were used to fit the 316 
drug release profile with the aid of Origin 8 software (Balcerzak & Mucha, 2010; Dash, Murthy, Nath 317 
& Chowdhury, 2010): 318 
  
ntkF   Eq. (1) 319 
    tkexp1
max
FF 1   Eq. (2) 320 
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max222
max222
Bmax1max  Eq. (3) 321 
where F is the fraction (in percentage) of drug released at a certain time t, Fmax stands for the 322 
maximum fraction of drug released during the total time period, and k1 and k2 are the first order kinetic 323 
coefficient and the kinetic coefficient for the second stage in min
-1
, respectively. In Eq. (1) n denotes 324 
the release exponent, while FB in Eq. (3) indicates the drug fraction released in the first release stage. 325 
The criterion of only validating a correlation when R
2 
>0.98 was adopted. 326 
The Gallagher-Corrigan model fitted ketoprofen release from pectin aerogel microparticles (R
2
>0.999, 327 
Table 2). This model fitting denotes a two-phase drug release profile, incorporating an initial burst 328 
release (phase I) followed by a slower polymeric matrix bulk degradation (erosion)-controlled release 329 
phase (phase II) (Gallagher & Corrigan, 2000). During the phase I, a fraction of 25.0% of the total 330 
non-crystalline drug (FB) easily dissolved once the matrix comes into contact with the surrounding 331 
aqueous medium, which meant that this fraction of drug was the most accessible one, being only 332 
physically adsorbed to the external surface or in large pores of the aerogel matrix. Ketoprofen fraction 333 
entrapped in the pectin microspheres represents 56.6% of drug molecules (Fmax-FB) and is only 334 
released out in the phase II after pectin aerogel matrix degradation. Moreover, pectin microspheres 335 
provided a rapid release profile with a significantly higher simulated degradation kinetic coefficient 336 
(k2=0.093 min
-1
) compared to diffusion kinetic coefficient (k1=0.023 min
-1
). This suggests a rapid bulk 337 
degradation process, which is attributed to the high hydrophilicity and chemical instability of pectin 338 
aerogels in pH 6.8 buffer solution. 339 
For ketoprofen release from alginate aerogel microspheres, both Korsmeyer-Peppas and Gallagher-340 
Corrigan models showed comparable fitting wellness (R
2
>0.99, Table 2). In this case, the diffusion 341 
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kinetic coefficient (k1=0.026 min
-1
) was higher than the degradation kinetic coefficient (k2=0.010 min
-342 
1
), suggesting that drug release is likely diffusion-controlled assisted by polysaccharide erosion. The n 343 
value of Korsmeyer-Peppas model below 0.43, an extreme value for spherical dosage forms (Ritger & 344 
Peppas, 1987), suggests the initial diffusion process of ketoprofen following the Fickian diffusion 345 
mechanism and endorses the diffusion-control hypothesis.  346 
First order kinetics was the best model fitting ketoprofen release from starch aerogel microspheres 347 
(R
2
=0.987) (Table 2). The wellness of the first order model fitting suggests that drug dissolution from 348 
starch aerogel microspheres is the governing factor of ketoprofen release where the solid matrix 349 
morphology remains intact during the dissolution process. Gallagher Corrigan model, with an 350 
excellent correlation and a significantly low k2 value, and Korsmeyer-Peppas model, with a n-value of 351 
0.40, endorsed a first-order model following the Fickian release. A prompt drug release from starch 352 
microspheres resulted in 53% of the total loaded drug dissolved in neutral medium in the first 60 min, 353 
followed by an increment of 3% in release rate within 24 h. Drug remaining in the starch aerogel may 354 
be forming an insoluble inclusion complex in the aerogel matrix.  355 
Release behavior of ketoprofen from aerogel microspheres was also investigated at acidic conditions 356 
(pH 1.2, gastric pH conditions), in order to determine their potential to promote fast release in the 357 
gastric environment (Figs. 6 and 7). Ketoprofen, as well many other non-steroidal anti-inflammatory 358 
drugs (NSAIDs) is characterized by a pH-dependent solubility profile due to their weak acid character 359 
(Sheng, Kasim, Chandrasekharan & Amidon, 2006). Thus, ketoprofen crystals (pKa 4.4-4.8) exhibit 360 
low solubility and dissolution rate under acidic conditions. Moreover, cross-linked pectin and alginate 361 
microspheres are resistant to acidic conditions and are not able to dissolve in aqueous media, likely 362 
influencing the release behavior of the drug incorporated to these carriers (Del Gaudio, Colombo, 363 
Colombo, Russo & Sonvico, 2005; Sriamornsak, 2003). The kinetic analysis of the ketoprofen release 364 
from alginate and pectin microsphere aerogels is summarized in Table 3. 365 
In contrast to drug release profiles at pH 6.8, alginate microspheres accelerated ketoprofen release at 366 
simulated gastric pH conditions (Fig. 6), which is consistent with previous reports (Radin, Chen & 367 
Ducheyne, 2009). pKa values of both alginate (1.5-3.5) and ketoprofen (4.4-4.8) are in the 1.2-6.8 pH 368 
range leading to different ionic forms of the drug and the carrier in PBS and simulated gastric fluid 369 
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conditions. Besides, non-crystalline drug molecules located in aerogel microspheres may require much 370 
less time for dissolution than pure ketoprofen crystals (Sheng, Kasim, Chandrasekharan & Amidon, 371 
2006). As denoted by the Korsmeyer-Peppas model, ketoprofen release from alginate aerogel 372 
microspheres at pH 1.2 mainly follows a diffusion profile similar to that obtained at pH 6.8, but with a 373 
higher value of the diffusion coefficient at pH 1.2. 374 
Ketoprofen release from pectin microspheres at pH 1.2 (Fig. 7) was slower than at pH 6.8 during the 375 
first 2 h, although again faster than the profile recorded for the free crystalline drug. After 2 h, drug 376 
release rate at acidic conditions exceeded the release rate at neutral conditions, finally reaching 98% 377 
drug released (compared to 80% released at pH 6.8). This finding can be well explained by the pectin 378 
matrix properties. The initial slower release rate at pH 1.2 is due to the lower swelling ratio of the 379 
pectin matrix at acidic conditions, due to the high proportion of unionized carboxylic groups. After a 380 
certain time period, the swelling effect decreases likely due to matrix degradation (Sriamornsak, 2003) 381 
and drug-pectin interaction should govern the drug release. Due to the small particle size of the 382 
aerogel microspheres, swelling and water uptake studies were not able to be carried out to confirm this 383 
effect, in contrast to other studies with small aerogel monoliths or gel beads both falling in the size 384 
range of few milimeters (Betz, García-González, Subrahmanyam, Smirnova & Kulozik, 2012; Del 385 
Gaudio, Colombo, Colombo, Russo & Sonvico, 2005), which can be both weighed or measured in a 386 
straightforward way. This behavior of pectin supports the final faster release rate of ketoprofen 387 
compared to that observed at pH 6.8 conditions. Accordingly, the kinetic coefficient obtained for 388 
pectin aerogels at pH 1.2 (k2=0.113 min
-1
) by the Gallagher Corrigan model is higher than that at pH 389 
6.8 (k2=0.093 min
-1
). Moreover, FB value at pH 1.2 (86.81%) is much higher than at pH 6.8 (24.98%), 390 
which is ascribed to the weaker ketoprofen-pectin interaction at pH 1.2 with respect to pH 6.8 due to 391 
the change in the ionic forms of both ketoprofen and pectin at these two pH conditions. 392 
The release behavior from starch aerogel microspheres of ketoprofen was compared to that of benzoic 393 
acid. Both drugs have similar chemical functionalities and dissociation constant values (pKa 4.2 for 394 
benzoic acid), but different molecular weights and dimensions. Moreover, the presence benzoic acid-395 
amylose inclusion complexes may influence on the release behavior of the drug. Starch microspheres 396 
loaded with benzoic acid showed the same release pattern at intestinal environment (pH 6.8) (Fig. 8) 397 
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as with ketoprofen, i.e. a burst release followed by a sustained release. Starch microspheres possess a 398 
strong hydrophilic character and water uptake is considered to be the main controlling mechanism in 399 
the initial burst period and the release period is complete within 30 min, as also reported by other 400 
researchers (Atyabi, Manoochehri, Moghadam & Dinarvand, 2006). The dissolution profile of pure 401 
benzoic acid was similar to that of the same drug loaded in the aerogel, but showing an initially slower 402 
release rate according to the k1 parameter from the first order release model fitting (0.160 min
-1
 for 403 
benzoic acid in the starch aerogels and 0.071 min
-1
 for pure benzoic acid) likely related to the 404 
amorphous state of the drug in the aerogel. However, with regard to the final benzoic acid release 405 
percentage, only 63% of the total loading content from starch microspheres was released into the 406 
aqueous medium whereas 90% pure benzoic acid was dissolved in the first two hours. This could be 407 
the consequence of closed trapping of solute drug molecules into the starch polymeric network by 408 
formation of chemical bonds (carboxylic group of benzoic acid with hydroxyl group of starch matrix) 409 
(Vyas & Jain, 1992) and the presence of amylose-benzoic acid inclusion complexes. Release of 410 
benzoic from starch aerogel microspheres was faster than that of ketoprofen with the same aerogel 411 
carrier. The difference in dissolution behavior between ketoprofen and benzoic acid may stem from the 412 
smaller dimension of benzoic acid, which makes it easier diffusing from starch polymeric network, 413 
and different drug-matrix interactions. 414 
4 Conclusions 415 
Different types of biodegradable polysaccharide-based aerogel microspheres including alginate, pectin 416 
and starch were evaluated regarding their feasibility to be used as drug carriers for life science 417 
applications. The processing method used provides a suitable morphology of the micronized carrier 418 
with improved product reproducibility, an amorphous drug-loaded delivery system with loadings in 419 
the range of 11-24 wt.%, and an expected good physicochemical stability upon storage because of the 420 
dry solid format of the formulation. Drug loading capacity was dependent on the specific surface area 421 
and surface chemistry of the aerogels as well as on the drug-aerogel matrix chemical interaction. 422 
Material hydrophilicity tests with a high-speed camera were suitable to unveil different erosion 423 
mechanism of the aerogel in contact with aqueous medium depending on the aerogel origin (fast 424 
erosion for pectin and alginate and slow erosion for starch aerogels). Release of ketoprofen from 425 
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alginate and pectin aerogel particles was sensitive to pH values of the aqueous medium (pH 1.2 or 6.8). 426 
Namely, alginate aerogel microspheres showed accelerated drug release behavior at simulated gastric 427 
pH conditions favoring ketoprofen dissolution at this point. The release profiles of the polysaccharide 428 
aerogel microspheres are governed by one or two release mechanisms depending on the aerogel 429 
matrix. This different drug release behavior observed for polysaccharide aerogel matrices opens up the 430 
possibility of using these nanostructured materials as carriers for developing tailor-made drug release 431 
profiles for oral applications.  432 
433 
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Table 1. Physical properties and drug loading capacities for aerogel microspheres. 1 
 2 
Aerogel 
matrix 
Mean  
particle size 
[μm]a 
Specific 
surface area 
[m
2
/g]
b
 
Drug loading 
[wt.%] 
Drug entrapment efficiency 
[%]
c
 
Specific loading 
[g/m
2
] 
Ketoprofen Benzoic acid Ketoprofen Benzoic acid Ketoprofen Benzoic acid 
Silica 155±7 1000±50 15.38±1.80 23.77±0.12 18.18±2.51 31.18±0.21 
1.54×10-4± 
1.80 ×10-5 
2.38×10-4± 
6.50×10-6 
Alginate 116±6 524±26.4 11.83±0.61 18.92±1.32 13.42±0.78 23.33±2.01 
2.26×10-4± 
1.17×10-5 
3.61×10-4± 
2.51×10-5 
Pectin 498±1 397±19.9 14.01±3.84 14.66±1.24 16.29±5.19 17.18±1.70 
3.53×10-4± 
9.66
 ×10-5 
3.69×10-4± 
3.15×10-5 
Starch 519±4 127±6.4 12.84±0.92 21.54±2.04 14.73±1.21 27.45±3.31 
10.1×10-4±  
7.24 ×10-5 
17.0×10-4± 
1.61×10-4 
a Obtained prior to supercritical drying. A particle size decrease of 5-10% is expected after drying 3 
b Obtained prior to supercritical impregnation 4 
c Note that the remaining drug fraction is recovered in the form of dry powder in the drug cartridge and can be virtually reused for ulterior trials 5 
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Table 2. Kinetic fitting parameters of the ketoprofen release from drug-loaded aerogel microparticles in 8 
pH 6.8 buffer solution. Bold values denote the best-fit parameters for each ketoprofen-aerogel system 9 
 10 
Samples First Order Korsmeyer-Peppas Gallagher Corrigan 
Fmax 
(%) 
k1(min
-
1
) 
R
2 k(min-
n
) 
n R2 FB 
(%) 
k1(min
-
1
) 
Fmax 
(%) 
t2max(min) k2(min
-
1
) 
R2 
Pectin 81.65 0.032 0.985 3.48 0.77 0.983 24.98 0.023 81.57 22.87 0.093 0.9995 
Alginate 89.99 0.028 0.923 12.86 0.40 0.998 50.74 0.026 97.08 42.70 0.010 0.998 
Starch 54.90 0.075 0.987 12.18 0.40 0.953 47.96 0.068 57.21 -306.3a 0.002 0.9991 
a This unrealistic negative value of t2max is likely a numerical incertitude problem arising from the very low value of k2.  11 
12 
3 
Table 3. Kinetic analysis of the ketoprofen release from drug-loaded aerogel microparticles in pH 1.2 13 
acidic environment. Bold values denote the best-fit parameters for each ketoprofen-aerogel system. 14 
Samples First Order Korsmeyer-Peppas Gallagher Corrigan 
Fmax  
(%) 
k1(min
-
1
) 
R
2 k(min-
n
) 
n R2 FB 
(%) 
k1(min
-
1
) 
Fmax 
(%) 
t2max(min) k2(min
-
1
) 
R2 
Pectin 95.51 0.014 0.996 1.38 0.93 0.991 86.81 0.015 92.90 373.76 0.113 0.997 
Alginate 92.85 0.051 0.949 16.66 0.41 0.967 79.55 0.031 96.12 35.50 -0.127 0.991 
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Figure Captions 1 
Fig. 1. Schematic diagram of supercritical CO2 impregnation equipment 2 
Fig. 2. SEM images of (a) pure alginate aerogel microspheres, (b) ketoprofen-loaded alginate 3 
microspheres, and (c) benzoic acid-loaded alginate microspheres. Scale bars represent either 2 µm (left) 4 
or 200 nm (right). Alginate microspheres were herein shown as representative examples of the 5 
polysaccharide aerogels studied.  6 
Fig. 3. X-ray diffraction patterns for:  Benzoic acid case study: (a) pure benzoic acid, (b) raw starch 7 
material, (c) unloaded starch aerogel microspheres, (d) physical mixture of starch aerogel microsphere 8 
with benzoic acid (15 wt.%), and (e) benzoic acid-loaded starch aerogel microspheres.  Ketoprofen case 9 
study: (f) pure ketoprofen, (g) physical mixture of starch aerogel microsphere with ketoprofen (15 wt.%), 10 
and (h) ketoprofen-loaded starch aerogel microspheres. Asterisk symbol indicates the main diffraction 11 
peak of benzoic acid–71-helix structure amylose inclusion complex. 12 
Fig. 4. Contact angle measurement test of starch, silica, pectin and alginate aerogel microspheres (in 13 
order from top to bottom). Pictures were taken before (left), at (center) and after (right) dosing a 100 14 
picoliter water droplet. The stop time of the test was selected when no further structure alteration was 15 
noticeable and corresponds to the so-called after deposition test in the figure. Projections of the contour 16 
lines of the particles before water contact are added in the pictures after water contact (dashed red 17 
lines) to facilitate the visual inspection of the water drop test. 18 
Fig. 5. In vitro release profiles at pH 6.8 (0.1 M phosphate buffer saline solution) of ketoprofen from 19 
starch (squares), alginate (diamonds), pectin (circles) and silica (pluses) aerogel microspheres (in solid 20 
lines). The dissolution pattern of the same amount of free drug (triangles and dotted line) is also plotted 21 
for comparison purposes. 22 
Fig. 6. In vitro release profiles of ketoprofen from alginate aerogel microspheres at two different pH 23 
media (solid lines). Release studies of the aerogels were carried out at 37ºC and pH 1.2 (0.1 N HCl, dark 24 
Figure Captions
2 
diamonds) and 6.8 (0.1 M phosphate buffer saline solution, blank diamonds). Release profiles of the raw 25 
ketoprofen (dotted lines) are also plotted for the sake of comparison (dark triangles for pH 1.2 and blank 26 
triangles for pH 6.8). 27 
Fig. 7. In vitro release profiles of ketoprofen from pectin aerogel microspheres at two different pH media 28 
(solid lines). Release studies of the aerogels were carried out at 37ºC and pH 1.2 (0.1 N HCl, dark circles) 29 
and 6.8 (0.1 M phosphate buffer saline solution; blank circles). Release profiles of the raw ketoprofen 30 
(dotted lines) are also plotted for the sake of comparison (dark triangles for pH 1.2 and blank triangles 31 
for pH 6.8). 32 
Fig. 8. Release profiles for starch aerogel particles loaded with benzoic acid (black squares) and 33 
ketoprofen (white squares) at 37ºC and pH 6.8 (0.1 M phosphate buffer saline solution) (in solid lines). 34 
Release profiles of the raw ketoprofen (triangles) and benzoic acid (crosses) are also plotted (in dotted 35 
lines) for the sake of comparison. 36 
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FIGURE 8 83 
SUPPLEMENTARY DATA 
A. Preparation of spherical aerogel microspheres [1] 
A.1 Pectin aerogel [2] 
Aerogel microspheres were obtained by stirring (500 rpm) an aqueous phase containing 6% 
(w/w) of pectin with the corresponding amount of canola oil to get a 3:1 (v/v) oil:pectin 
solution emulsion. Ethanol (50 wt% with respect to water content) was then added and the 
mixture was heated to 313 K for 30 min under agitation (500 rpm). Then, the system was 
cooled down to room temperature and continuously stirred at 2000 rpm. The dispersion was 
centrifuged to separate the pectin microparticles from the oil phase, immersed in 99.8% (v/v) 
EtOH and stored at room temperature during 24 h for aging. After a second solvent exchange 
to ethanol, the pectin gel was supercritically dried at 318 K, 11.0-12.0 MPa and CO2 flow of 2-4 
NL·min-1 during 4 h. 
A.2 Alginate aerogel [3] 
A 2 % (w/w) alginate aqueous solution-in-paraffin oil emulsion (2:1 (v/v) oil:alginate solution) 
was prepared upon stirring (1000 rpm) at room temperature for 15 min. Prior to the 
emulsification, CaCO3 was added to the alginate solution (Ca
2+/alginate=7.3 wt%) and Span 80 
surfactant (surfactant:oil volume ratio=1:99) was added to the oil phase. Gelation of the 
dispersed phase took place through the internal setting method by the addition of glacial 
acetic acid (acid-to-Ca2+ molar ratio=3.5). Gel microspheres were isolated through 
centrifugation and exposed to ethanol in a sequential solvent exchange (ethanol:water volume 
ratio 10:90, 30:70, 50:50, 70:30, 90:10, 99.99:0.01). Finally, aerogel microspheres were 
obtained by scCO2-assisted drying (318 K, 11.0-12.0 MPa, 2-4 NLCO2·min
-1, 4 h). 
A.3 Starch aerogel [4] 
A 2:1 volume phase ratio of a 15 % (w/w) corn starch dispersion in the corresponding amount 
of vegetable oil was prepared. The emulsion was heated in an autoclave to 393 K upon stirring 
(500 rpm) for 20 min. The emulsion was cooled down to room temperature while stirring at 
2000 rpm. Then, the particles were centrifuged to remove the oil and water phase, soaked in 
ethanol and then stored at 277 K for retrogradation during 48h. After a second solvent 
exchange to ethanol, the starch gel was supercritically dried at 318 K, 11.0-12.0 MPa and CO2 
flow of 2-4 NL·min-1 during 4 h. 
A.4 Silica aerogel [5,6] 
The sol (dispersed phase) was prepared in two steps: 1) Preparation of a 
TMOS:MeOH:water:HCl mixture with a molar ratio of 1:2.4:1.3:10-5 and dilution in ethanol; 2) 
Addition of water and ammonia solution to obtain a TMOS:MeOH:water:HCl:NH4OH mixture 
with a molar ratio of 1:2.4:4:10-5:10-2. The dispersed phase was mixed with the continuous 
phase (canola oil saturated with ethanol) to form the emulsion (sol:oil phase volume ratio=1:1) 
and stirred at 1300 rpm and room temperature for 20-30 min. After 24 h aging, the silica gel 
was filtered to remove the oil phase and then supercritically dried at 318 K, 11.0-12.0 MPa and 
CO2 flow of 2-4 NL·min
-1 during 4h. 
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